Columbia Financial (CLBK) EVP Jenifer White Reports Stock Acquisition and Option Holdings
Rhea-AI Filing Summary
Insider purchase and holdings summary for Columbia Financial, Inc. (CLBK): On 09/05/2025, Jenifer White (EVP & CHRO) was reported to have acquired 35.489 units of common stock at a price of $15.01 under the Columbia Bank Stock Based Deferral Plan, with settlement to be made in shares upon distribution. The filing lists multiple classes of her current beneficial ownership across plans and awards, including direct holdings and indirect holdings through an ESOP, SERP, SIM and several stock award tranches.
The report also discloses outstanding stock options exercisable into common stock: 5,540 options at $20.54 (exp. 10/31/2032), 6,203 at $15.94 (exp. 05/01/2033), 5,107 at $16.49 (exp. 03/06/2034), and 11,297 at $16.23 (exp. 03/03/2035). The Form 4 was signed by a power of attorney on 09/09/2025.
Positive
- Insider acquisition recorded: 35.489 units purchased at $15.01
- Detailed transparency: Filing lists direct and indirect holdings across multiple plans and award tranches, aiding investor visibility
- Clearly disclosed option positions: 5,540; 6,203; 5,107; and 11,297 options with stated exercise prices and expirations
Negative
- None.
Insights
TL;DR: An insider purchase and a detailed breakdown of equity compensation holdings were reported; disclosure is routine and not clearly material.
The filing documents a small purchase executed through a deferred compensation plan and enumerates multiple indirect holdings and equity awards subject to vesting and performance conditions. This is consistent with typical executive compensation structures: phantom stock units, multiple tranches of performance- and time-based awards, and outstanding options with staggered expirations. The disclosure improves transparency about dilution and potential future share issuance but does not, by itself, indicate a material corporate event.
TL;DR: Reported acquisition at $15.01 plus several exerciseable option tranches; no earnings or transaction altering company valuation disclosed.
The transaction shows acquisition of 35.489 stock units at $15.01 via the Stock Based Deferral Plan and lists existing option positions totaling 28,147 exercisable shares across four option grants with exercise prices between $15.94 and $20.54. The disclosure allows investors to track insider exposure and potential future dilution from option exercises and deferred-plan settlements, but the filing contains no revenue, profit, or corporate-action data to change an investment thesis.